Bioqube Ventures

Bioqube Ventures company information, Employees & Contact Information

Explore related pages

Related company profiles:

Bioqube Ventures, founded in 2015 by Debora Dumont and Nico Vandervelpen, is a specialist life sciences investment firm based in Europe and US with a global footprint. We source, finance and develop innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors. Bioqube Ventures is dedicated to funding therapeutic innovations: … a life sciences venture capital fund – dedicated to advancing exciting science in European and US ecosystems to breakthrough therapies for patients. … a fit-for-purpose dual investment model – besides more classical investments in investment rounds, we have special attention for venture creation projects that require additional experiments prior to creating new ventures. With our in-house factory model we are able to translate exciting science into trailblazing companies. … a hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths. We believe in putting our expertise at work where it matters.

Company Details

Employees
15
Founded
-
Address
Brussels, Be
Email
in****@****res.com
Industry
Venture Capital And Private Equity Principals
NAICS
Miscellaneous Intermediation
HQ
Brussels
Looking for a particular Bioqube Ventures employee's phone or email?

Bioqube Ventures Questions

News

Actithera raises $75.5 million in oversubscribed Series A financing to redefine precision radioligand therapy - Arctic Today

Actithera raises $75.5 million in oversubscribed Series A financing to redefine precision radioligand therapy Arctic Today

Egle Therapeutics raises 40 million € Series Ato develop First-In-Class T-regulatory cells therapies based on Treg-starvers - Institut Curie - Espace presse

Egle Therapeutics raises 40 million € Series Ato develop First-In-Class T-regulatory cells therapies based on Treg-starvers Institut Curie - Espace presse

Top Bioqube Ventures Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant